ppt ebm ayu

Upload: ayuwijayantii

Post on 28-Feb-2018

238 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/25/2019 ppt EBM ayu

    1/21

    CRITICAL APPRAISAL

    DIAGNOSTICTYPHIDOT M AND DIAZO TEST VIS--VIS

    BLOOD CULTURE AND WIDAL TEST IN THE

    EARLY DIAGNOSIS OF TYPHOID FEVER IN

    CHILDREN IN A RESOURCE POOR SETTING

    Ayu Wijayanti

    1102009049

    dr. Aryenti, M. Sc

  • 7/25/2019 ppt EBM ayu

    2/21

    SKENARIO

    Seorang ere!"an #er"$%a &' (a)"n *a(ang *engan+e,")an *e!a! $e*a) +"rang ,e#%) $e!%ngg"- na.$"!a+an #er+"rang- *%are- "$%ng- !"a,- !"n(a)- #era(#a*an !en"r"n/ Se(e,a) *%,a+"+an e!er%+$aan 0$%+

    *%(e!"+an TD 1'23'- na*% &''42!en%(- ,%*a) +o(or- $")"("#") 516C- +ea*aan "!"! ,e!a)/ Pa$%en !e!%,%+%+e#%a$aan 7a7an $e!#arangan *% $e+o,a) *an,%ng+"ngann8a/ D"gaan $e!en(ara *o+(er a*a,a) *e!a!(%.o%* (e(a% "n("+ !enega++an *%agno$%$ a$(%- *o+(er

    !er"7"+ "n("+ !e,a+"+an e!er%+$aan "7% 9%*a,/Pe!er%+$aan (er$e#"( !e!#"(")+an 9a+(" 8ang ,a!a/Orang ("a a$%en #er(an8a aa+a) a*a e!er%+$aan ,a%n8ang (%*a+ !e!#"(")+an 9a+(" 8ang ,a!a agar ana+n8a

    $egera *%(angan% $e$"a% *engan *%agno$%$ a$(%n8a/

  • 7/25/2019 ppt EBM ayu

    3/21

    Pertanyaan (foreground question)

    Aa+a) (er*aa( e!er%+$aan $e,a%ne!er%+$aan 9%*a, 8ang )a$%,n8a ,e#%):ea( +e,"ar *%#an*%ng+an *engan

    e!er%+$aan 9%*a, 8ang !e!#"(")+an9a+(" 8ang ,a!a ;

  • 7/25/2019 ppt EBM ayu

    4/21

    P I C O

    Po",a(%on < Pere!"an *%*"ga !enga,a!% demamtifoid

    In(er=en(%on< Me,a+"+an e!er%+$aan 9%*a, (e$( "n("+!enega++an *%agno$%$ a$(% 8ang !e!#"(")+an 9a+("

    ,e#%) ,a!a Co!ar%$on < Me,a+"+an e!er%+$aan T8)%*o( M a(a"

    *engan e!er%+$aan *%a>o (e$( "n("+ !enega++an*%agno$%$ a$(% *engan !e!er,"+an 9a+(" 8g ,e#%) :ea(

    O"(:o!e$ < Dengan !e,a+"+an e!er%+$aan T8)%*o(

    M a(a" *engan e!er%+$aan *%a>o (e$(- *%agno$%$*e!a! (%.o%* *aa( *%(ega++an *engan 9a+(" 8ang ,e#%):ea(

  • 7/25/2019 ppt EBM ayu

    5/21

    VALIDITY

  • 7/25/2019 ppt EBM ayu

    6/21

    Menen("+an a*a a(a" (%*a+n8aer#an*%ngan 8ang *%,a+"+an $e:ara%n*een*en( *an #,%n* (er)a*a $"a("

    $(an*ar r"7"+an ?go,* $(an*ar@;

    Tidak, di jurnal ini tidak dijelaskan

    tentang perbandingan yangdilakukan secara independent danblind terhadap suatu standarrujukan (gold standard)

  • 7/25/2019 ppt EBM ayu

    7/21

    Menen("+an +e$e$"a%an an(ara $a!,ea$%en ene,%(%an *engan $e+(r"!en*er%(a a*a $e((%ng ra+(%+ +,%n%+ $aa(

    "7% *%agno$(%+ (er$e#"( a+an*%a,%+a$%+an/

    Ya, Terdapat kesesuaian antara

    partisipan di jurnal dengan pasienpada setting klinik

  • 7/25/2019 ppt EBM ayu

    8/21

    Menen("+an a*a a(a" (%*a+n8a r"7"+an$(an*ar *%,a+"+an (ana !e,%)a( )a$%, "7%*%agno$(%:

    Ya- (er*aa( go,* $(an*ar 8ang*%(a!%,+an *a,a! 7"rna, %n% 8a%(" %$o,a$%#a+(er%

  • 7/25/2019 ppt EBM ayu

    9/21

    IMPORTANCE

  • 7/25/2019 ppt EBM ayu

    10/21

    Menen("+an $en$%(%=%(8- $e:%0:%(8- LR

    iya, Sensitivitas dan spesiftasditampilkan dalam jurnal

  • 7/25/2019 ppt EBM ayu

    11/21

  • 7/25/2019 ppt EBM ayu

    12/21

  • 7/25/2019 ppt EBM ayu

    13/21

  • 7/25/2019 ppt EBM ayu

    14/21

    Tabel 1 Likelihood

    ratio (!

    Likelihood

    ratio ("!

    Widal test 1.33 0.67

    Typhidot M

    test

    0 0.1

    Diazo test 21.5 0.23

    Tabel # Likelihood

    ratio (!

    Likelihood

    ratio ("!

    Widal test17.75 00.75

    Typhidot M

    test

    0 0.11

    Diazo test 11.42 0.21

    Tabel 2 Likelihood ratio

    (!

    Likelihood ratio

    ("!

    Blood Culture 0 0.72

    Widal test 0 0.11

    Typhidot M test 7.11 0.38

    Diazo test 5.6 0.22

    Tabel 4 Likelihood

    ratio (!

    Likelihood

    ratio ("!

    Blood Culture 0 0.6

    Widal test 16.56 0.61

    Typhidot M test 0 0.14

    Diazo test 1.75 0.21

  • 7/25/2019 ppt EBM ayu

    15/21

    APPLICABILIT

  • 7/25/2019 ppt EBM ayu

    16/21

    Menen("+an +e!"ng+%nan eneraana*a a$%en ?a=a%,a#,e- aor*a#,e-a::"ra(e- re:%$e@

    AVAILABLE :

    Un("+ (8)%*o( (e$( (%*a+ (er$e*%a *%+,%n%+ / a,a( (er$e#"( !e!#"(")+an

    (e+)n%+ *%,a#o,a(or%"! 8ang (er,%#a((e(a% 9a+(" 8ang *%#"(")+an "n("+*%agno$%$ (%*a+ ,a!a/

  • 7/25/2019 ppt EBM ayu

    17/21

    Un("+ *%a>o (e$( !"ng+%n *aa(*%(era+an +arena !"*a) *%,a+"+an *an(%*a+ !e!#"(")+an 9a+(" 8ang ,a!a

  • 7/25/2019 ppt EBM ayu

    18/21

    AFFORDABLE :

    Ya/ Un("+ *%a>o (e$( +arena ,e#%) !"ra)*an (er7ang+a" "n("+ ra+8a( !enenga)

    +e#a9a)

  • 7/25/2019 ppt EBM ayu

    19/21

    TABEL 3

    W%*a, (e$( '/T8)%*o( M = '/1D%a>o (e$( '/F

    TABEL 4

    B,oo* C",("re '/3W%*a, (e$( '/3

    T8)%*o( M =

    '/1D%a>o (e$( '/1

    ACCURATE

    TABEL 1

    W%*a, (e$( '/3

    T8)%*o( M '/1

    D%a>o (e$( '/1

    TABEL 2

    B,oo* C",("re '/F

    W%*a, (e$( '/

    T8)%*o( M '/1

    D%a>o (e$( '/

  • 7/25/2019 ppt EBM ayu

    20/21

    PRECISE

    Menen("+an er)%("ngan re(e$(ro#a#%,%(8 a$%en

    P ! (A"C)#(A"B"C"$)Ta#e, & < '/& ?P5'2&F@

    Ta#e, < '/3 ?P&&'2&F@

    Ta#e, 5 < '/FF ?P'2&F@Ta#e, < '/ ?P12&F@

  • 7/25/2019 ppt EBM ayu

    21/21

    TERIMAKASIH

    WASSALAMUALAIKUM WR/ WB